Tn antigen-driven downregulation of podoplanin promotes colorectal cancer invasion

doi:10.3748/wjg.121494

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 35

This Article

(3)

(0)

(1)

(26)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Sep 21, 2026; 32(35): 121494
Published online Sep 21, 2026. doi: 10.3748/wjg.121494

Full Size Figure Download Figure

Figure 6 O-glycosylation-deficient podoplanin promotes tumor growth. A: Effect of abnormal O-glycosylation of podoplanin on tumor growth and proliferation in a BALB/c nude mouse model; B: Tumor volume comparison; C: Tumor growth curve; D: Cell proliferation in tumors was assessed by immunohistochemical staining for Ki67, and representative images are displayed. PDPN: Podoplanin; WT: Wild-type; mu: O-glycosylation-mutated.

Citation: Fan LW, Wu XZ, Liu ZW, Lin Q, Du JX, Tian YT, Dong XC, Xu DK. Tn antigen-driven downregulation of podoplanin promotes colorectal cancer invasion. World J Gastroenterol 2026; 32(35): 121494
URL: https://www.wjgnet.com/1007-9327/full/v32/i35/121494.htm
DOI: https://dx.doi.org/10.3748/wjg.121494

Fan LW, Wu XZ, Liu ZW, Lin Q, Du JX, Tian YT, Dong XC, Xu DK. Tn antigen-driven downregulation of podoplanin promotes colorectal cancer invasion. World J Gastroenterol 2026; 32(35): 121494 [DOI: 10.3748/wjg.121494]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.